Caplight Directory>Investors>Trinity Innovation Fund>Trinity-fund


Trinity Innovation Fund

Trinity Innovation Fund

Beijing, Beijingtrinity-fund.com

Overview

Trinity Innovation Fund (TIF) is a venture capital firm founded in 2018 and based in Beijing, China. It specializes in early and growth-stage investments in the biomedical, biotechnology, drug discovery, and pharmaceutical industries. The firm operates with a philosophy described as the "Triad of scientists, managers and investors". TIF also has a Singapore-based entity, Trinity Innovation Bioventure Singapore (TIBS), which is part of the Trinity Innovation Fund group and focuses on the Asian market.

Portfolio Companies

8

Investments

CompanyDateStageLead
Vibrant TherapeuticsAug 2025Series ALead
Adcentrx TherapeuticsDec 2023Series A ExtensionCo-investor
Cholesgen PharmaceuticalJun 2023Series ACo-investor
Adcentrx TherapeuticsApr 2023Series ACo-investor
Epigenic TherapeuticsAug 2022SeedCo-investor
View all investments

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersBeijing, Beijing
Year FoundedN/A

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.





Caplight Logo




Use CasesInvestorsEmployees

CompaniesAll Companies

LegalPrivacy PolicyTerms of UseBrokerCheckForm CRS


Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.